Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries-Reference-Cited by-同舟云学术

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

Published:2018-06-25 Issue:1 Volume:18 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Bazargani Y. T.,Ugurlu M.,de Boer A.,Leufkens H. G. M.,Mantel-Teeuwisse A. K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-018-0858-5.pdf

Reference72 articles.

1. Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease Prevention and Control. In: Mendis S, editor. World Health Organization. 1st ed. Geneva: World Health Organization; 2011. p. 2–14.

2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.

3. Gaziano TA. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart. 2008 Feb;94(2):140–4.

4. Bovet P, Paccaud F. Cardiovascular disease and the changing face of global public Health : a focus on low and middle income countries. Public Health Rev. 2011;33(2):397–415.

5. Mendis S, Alwan A. A prioritized research agenda for prevention and control of noncommunicable diseases. 1st ed. Geneva: World Health Organization; 2011.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Essential medicines for cardiovascular diseases in India: Rapid appraisal of policies and processes at the subnational level;The National Medical Journal of India;2023-04-28

2. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list;Journal of Pharmaceutical Policy and Practice;2022-12-08

3. Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2022-05

4. Pharmacological assessment of zebrafish-based cardiotoxicity models;Biomedicine & Pharmacotherapy;2022-04

5. Associations between essential medicines and health outcomes for cardiovascular disease;BMC Cardiovascular Disorders;2021-03-25